News Daily News Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Caitlin E. Cox October 22, 2025
News Daily News High Aerobic Fitness Linked to Less Chronic Disease in Later Life Michael O'Riordan October 10, 2025
News Daily News Lower-Calorie Mediterranean Diet Plus Exercise Boosts Diabetes Prevention Todd Neale August 25, 2025
News Daily News AI-Supported Coaching Shows Promise for Improving Glycemic Control L.A. McKeown August 25, 2025
News Daily News Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC Yael L. Maxwell August 18, 2025
News Daily News Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks Michael O'Riordan August 01, 2025
News Daily News Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT Michael O'Riordan July 31, 2025
News Daily News Prepregnancy CV Health Portends Midlife Risks: CARDIA Analysis L.A. McKeown June 27, 2025
News Daily News Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC Michael O'Riordan June 25, 2025
News Daily News Weight-Loss Drug MariTide Gains Momentum in Phase II Trial Caitlin E. Cox June 25, 2025
News Daily News Majority of US Adults Have High Long-term Risk of CVD: NHANES Michael O'Riordan June 13, 2025
News Daily News Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says Todd Neale June 06, 2025
News Daily News Poor Cardiometabolic Health in Pregnancy Tied to Higher BP for Young Offspring Caitlin E. Cox May 15, 2025
News Daily News Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds Michael O'Riordan April 25, 2025
News Daily News Oral GLP-1 Drug Shines in Phase III ACHIEVE-1 Trial, Lilly Says Caitlin E. Cox April 17, 2025
News Daily News Weekend Warriors Also See Mortality Benefits With Exercise Michael O'Riordan April 10, 2025
News Daily News GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm Caitlin E. Cox February 26, 2025